Propel Bio Management »

Fidelity Inv Mmtrsy 1 680 shares owned by Propel Bio Management

Quarter-by-quarter ownership of Fidelity Inv Mmtrsy 1 680 shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Fidelity Inv Mmtrsy 1 680

Tip: Access up to 7 years of quarterly data

All positions including Fidelity Inv Mmtrsy 1 680 held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fidelity Inv Mmtrsy 1 680 by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.8M 4.8M 1.00

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Fidelity Inv Mmtrsy 1 680

Propel Bio Management

View all funds holding Fidelity Inv Mmtrsy 1 680